Literature DB >> 3954973

Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia.

P Runge, D P Muller, J McAllister, D Calver, J K Lloyd, D Taylor.   

Abstract

Six patients with abetalipoproteinaemia are described who received large doses of oral vitamin E for between 12 and 18 years in addition to a low fat diet and supplements of the other fat soluble vitamins. The progressive retinopathy observed in untreated abetalipoproteinaemia was substantially modified and most probably prevented by this therapy. Angioid streaks were noted in one patient. Treatment with vitamin A alone did not prevent or arrest the progression of the retinal lesion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954973      PMCID: PMC1040960          DOI: 10.1136/bjo.70.3.166

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  26 in total

1.  A-BETA-LIPOPROTEINAEMIA.

Authors:  C C FORSYTH; J K LLOYD; A S FOSBROOKE
Journal:  Arch Dis Child       Date:  1965-02       Impact factor: 3.791

2.  A-BETA-LIPOPROTEINAEMIA WITH SPECIAL REFERENCE TO THE VISUAL DEFECT.

Authors:  O H WOLFF; J K LLOYD; E L TONKS
Journal:  Exp Eye Res       Date:  1964-12       Impact factor: 3.467

3.  On having no beta-lipoprotein. A syndrome comprising a-beta-lipoproteinaemia, acanthocytosis, and steatorrhoea.

Authors:  H B SALT; O H WOLFF; J K LLOYD; A S FOSBROOKE; A H CAMERON; D V HUBBLE
Journal:  Lancet       Date:  1960-08-13       Impact factor: 79.321

4.  [The congenital abscence of beta-lipoproteins].

Authors:  M LAMY; J FREZAL; J POLONOVSKI; J REY
Journal:  C R Seances Soc Biol Fil       Date:  1960

5.  Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia.

Authors:  D P Muller; J K Lloyd
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  Angioid streaks in a case of beta thalassaemia major.

Authors:  J M Gibson; P R Chaudhuri; A R Rosenthal
Journal:  Br J Ophthalmol       Date:  1983-01       Impact factor: 4.638

7.  Angioid streaks associated with hereditary spherocytosis.

Authors:  N J McLane; W S Grizzard; B G Kousseff; R C Hartmann; R J Sever
Journal:  Am J Ophthalmol       Date:  1984-04       Impact factor: 5.258

8.  Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia.

Authors:  S Bishara; S Merin; M Cooper; E Azizi; G Delpre; R J Deckelbaum
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

9.  Vitamin E and neurological function.

Authors:  D P Muller; J K Lloyd; O H Wolff
Journal:  Lancet       Date:  1983-01-29       Impact factor: 79.321

10.  Nervous and ocular disorders in children with cholestasis and vitamin A and E deficiencies.

Authors:  F Alvarez; P Landrieu; P Laget; F Lemonnier; M Odièvre; D Alagille
Journal:  Hepatology       Date:  1983 May-Jun       Impact factor: 17.425

View more
  10 in total

Review 1.  Ophthaproblem. Vitamin A and vitamin E.

Authors:  Shaun Segal; Sanjay Sharma
Journal:  Can Fam Physician       Date:  2005-08       Impact factor: 3.275

2.  Microsomal triglyceride transfer protein gene mutations in Turkish children: A novel mutation and clinical follow up.

Authors:  Mehmet Gündüz; Eda Özaydın; Müge Büyüktaşlı Atar; Nevra Koç; Ceyda Kırsaçlıoğlu; Gülşen Köse; Angelo Baldassare Cefalù; Maurizio Averna; Patrizia Tarugi
Journal:  Indian J Gastroenterol       Date:  2016-05-10

Review 3.  The eye and inherited metabolic disease: a review.

Authors:  A Michalski; J V Leonard; D S Taylor
Journal:  J R Soc Med       Date:  1988-05       Impact factor: 5.344

Review 4.  Vitamin E in renal therapeutic regiments.

Authors:  Mohamed Alaa Thabet; James C M Chan
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

5.  Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.

Authors:  Charlotte Cuerq; Emilie Henin; Lioara Restier; Emilie Blond; Jocelyne Drai; Christophe Marçais; Mathilde Di Filippo; Christian Laveille; Marie-Caroline Michalski; Pierre Poinsot; Cyrielle Caussy; Agnès Sassolas; Philippe Moulin; Emmanuelle Reboul; Sybil Charriere; Emile Levy; Alain Lachaux; Noël Peretti
Journal:  J Lipid Res       Date:  2018-07-18       Impact factor: 5.922

Review 6.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

Review 7.  Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management.

Authors:  Jooho Lee; Robert A Hegele
Journal:  J Inherit Metab Dis       Date:  2013-11-28       Impact factor: 4.982

8.  High bioavailabilty of alpha-tocopherol loaded into poly (DL-lactic-co-glycolic acid) microspheres in apolipoprotein B knockout mice.

Authors:  Koichi Yokogawa; Yuichiro Shima; Tomoka Hashimoto; Makoto Hiyajyo; Kaori Kadoyama; Junko Ishizaki; Masaaki Nomura; Ken-ichi Miyamoto
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

9.  A Male Infant with Abetalipoproteinemia: A Case Report from Iran.

Authors:  Parisa Rashtian; Mehri Najafi Sani; Rozita Jalilian
Journal:  Middle East J Dig Dis       Date:  2015-07

Review 10.  Abetalipoproteinemia: two case reports and literature review.

Authors:  Rola Zamel; Razi Khan; Rebecca L Pollex; Robert A Hegele
Journal:  Orphanet J Rare Dis       Date:  2008-07-08       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.